Opioid analgesic therapy in pain management: how we got here from there
|
|
- Emma Goodwin
- 6 years ago
- Views:
Transcription
1 National Organization of Alternative Programs March 17, 2016 Opioid analgesic therapy in pain management: how we got here from there Gary M. Reisfield, M.D. Divisions of Addiction Medicine and Forensic Psychiatry University of Florida College of Medicine
2
3
4
5 91 st Annual Session of AMA June 12, 1940
6
7 If you re over 50 and you wake up in the morning without pain, you might not be alive anymore. Russian saying
8 John J. Bonica, M.D.
9 Cicely Saunders, M.D.
10
11 New Engl J Med 1980;302(2):123
12
13 Portenoy: n = 24 receiving Rx opioids n = 3 with abuse/addiction n = 1 refused to answer questions
14
15
16
17
18
19
20
21
22 Van Zee A. The promotion and marketing of OxyContin: commercial triumph, public health tragedy. Am J Public Health 2009;99(2):
23
24
25
26 Retail sales of prescription opioids 732% 244% 196% 1177% Graph: Manchikanti L. Singh A. Pain Physician 2008;11:S63-S88 Data:
27 Morphine, distribution of consumption, 2013 International Narcotics Control Board Narcotic Drugs: Estimated World Requirements for 2015
28 Fentanyl: distribution of consumption, 2013 International Narcotics Control Board Narcotic Drugs: Estimated World Requirements for 2015
29 Hydrocodone: global consumption, U.S. accounted for 99+% of world hydrocodone consumption in 2013 International Narcotics Control Board Narcotic Drugs: Estimated World Requirements for 2015
30 Oxycodone: global consumption, U.S. accounted for 78% of world oxycodone consumption in 2013 International Narcotics Control Board Narcotic Drugs: Estimated World Requirements for 2015
31 Methadone: global consumption, U.S. accounted for 51% of world methadone consumption in 2013 International Narcotics Control Board Narcotic Drugs: Estimated World Requirements for 2015
32
33 Deaths from unintentional drug overdoses in U.S., Okie S. A flood of opioids, a rising ride of deaths. New Engl J Med 2010;363(21):
34 Deaths from unintentional drug overdoses in U.S. by drug type Okie S. A flood of opioids, a rising ride of deaths. New Engl J Med 2010;363(21):
35 Prescription opioid deaths Source: National Center for Health Statistics, CDC Wonder
36
37
38
39 Florida Fun Facts In 2010: 98/100 top oxycodonedispensing physicians in U.S. practice in Florida By far, more oxycodone is dispensed in Florida than in the remaining 49 states combined
40 Top 10 reasons why your pain clinic may be a pill mill
41 Number 10
42 Number 9
43 #8
44 Number 7
45 Number 6
46 Number 5
47 Number 4
48 Number 3
49 Number 2
50 Number 1
51
52 Dec. 17, 2012 Did I teach about pain management, specifically about opioid therapy, in a way that reflects misinformation? Well, against the standards of 2012, I guess I did. We didn t know then what we know now. I gave innumerable lectures in the late 1980s and 90s about addiction that weren t true.
53
54
55
56 Shifting patterns of opioid abuse Cicero TJ, et al. N Engl J Med 2015;373:
57
58
59
60
61
62
63
64
65
66
67
68
69
70 Multidisciplinary pain management redux Medical Management Lifestyle changes Interventional Techniques Psychiatry Psychology Complementary & Alternative Therapies Physical & Rehabilitative Therapies
71 Risks Benefits
72
73 Primary care management Opioid risk stratification Low risk Moderate risk High risk Primary care management with specialist support Specialist management ORT score: 0-3 ORT score: 4-7 ORT score: 8 No Past/current SUD No FH of SUD No Major/untreated ψ Mild-moderate pain and/or disability Consistent UDT Consistent PDMP ± past SUD ± FH SUD ± past or current ψ Moderate pain and/or disability Consistent UDT Consistent PDMP Active SUD ± FH SUD Major untreated ψ Mod-severe pain and/or disability Inconsistent UDT Inconsistent PDMP Poor social support Adapted from: Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients. Pain 2005;6: Gourlay DL, Heit HA. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:
74
75
76 New York Times, December 11, 2015
77 Доверяй, но проверяй
78
79
80
81 What is (and isn t) in the urine Michna E, Jamison RN, Pham LD, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain 2007; 23:
82
83 Passik SD, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004;26:
84
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible
More informationOpioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM
Western Occupational Health Conference September 14, 2012 Opioid - Use & Misuse Scott Levy, MD MPH FACOEM Steven Feinberg, MD, MPH Disclosure Information Western Occupational Health Conference 2012 Steven
More informationOpioid Therapy, Pain, and Addiction at the Crossroads
Disclosure Opioid Therapy, Pain, and Addiction at the Crossroads Steven D. Passik, PhD Steven D. Passik, PhD Vice President, Clinical Research and Advocacy Millennium Health Principal Investigator Millennium
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationConsiderations for Safe Opioid Prescribing and Use. October 23, 2014
Considerations for Safe Opioid Prescribing and Use October 23, 2014 1 Webinar Agenda Welcome & Introductions Carolyn Konfirst, Patient Safety/Quality Advisor, Indiana Hospital Association Considerations
More informationOverview of the Opioid Addiction Epidemic
Overview of the Opioid Addiction Epidemic Presenter: Dr. Andrew Kolodny Moderator: Cindy Rodgers Audio will begin at 3:00PM ET. You can listen through your computer speakers or call 866-835-7973 Meeting
More informationMichael M. Miller, MD, FASAM, FAPA
Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical
More informationThe Prescription Opioid and Heroin Crisis: Responding to An Epidemic of Addiction
The Prescription Opioid and Heroin Crisis: Responding to An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible
More informationSAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM
Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure
More informationRisk Reduction Strategies in Pain Management
Risk Reduction Strategies in Pain Management Melissa J. Durham, PharmD, MACM, BCACP, DAAPM Assistant Professor of Clinical Pharmacy USC School of Pharmacy Clinical Pharmacist, The USC Pain Center Learning
More informationOpioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016
Opioids: What You Should Know About Opioid Prescribing Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Contact Information Denis G. Patterson, DO Nevada Advanced Pain Specialists
More informationInterventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?
Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference? Richard C. Dart, MD, PhD Executive Director of RADARS System, Denver, Colorado Professor, University
More informationOpioid Prescribing: Avoiding Pitfalls and Employing Safe Strategies. Essentials in Pain Management: Update 2017 Michael Weinberger MD
Opioid Prescribing: Avoiding Pitfalls and Employing Safe Strategies Essentials in Pain Management: Update 2017 Michael Weinberger MD The Problem 2015 52,404 2016 64,070 20% increase The Problem Drug
More informationAddressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain
Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Ajay D. Wasan, MD, MSc Professor of Anesthesiology and Psychiatry Vice Chair for Pain Medicine, Department of Anesthesiology University
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Institute for Behavioral Health Schneider Institutes
More informationFigure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School
More informationGold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?
Gold Standard for Urine Drug Testing Developed by TRMC Pain Management Center Jill Duffy, RN,BC Pam Kennell, RN, BC Heidi Beisch, RN Urine Drug Testing A DIAGNOSTIC tool For an OBJECTIVE test Based on
More informationOpioid Use Disorder. A Telligen White Paper. Katy Brown, PharmD Clinical Pharmacy Specialist
Opioid Use Disorder A Telligen White Paper Katy Brown, PharmD Clinical Pharmacy Specialist Opioid Use Disorder The use and misuse of opioids has steadily increased since the late 1990 s. When used as prescribed,
More informationIdentification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,
More informationEasy ways to save patients lives: How to prevent, recognize and deter prescription drug abuse.
Easy ways to save patients lives: How to prevent, recognize and deter prescription drug abuse. Chris Stock, PharmD, BCPP Professor (Adjunct), U of U Clinical Pharmacy Specialist, VAMC 1 Attending the presentation
More informationLisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR
Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR 1 1. Skin disorders, including cysts, acne, and dermatitis. 2. Joint disorders, including osteoarthritis. 3. Back problems. Source: Mayo
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School
More informationASPMN Conference Baltimore, Maryland
ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled
More informationCategory 4 Can we prove that ADF opioids really are?
Human Abuse Liability & Abuse-Deterrent Formulations Category 4 Can we prove that ADF opioids really are? March 7, 2016 Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center Executive
More informationREB CLOSE, MD Community Hospital of the Monterey Peninsula
REB CLOSE, MD Community Hospital of the Monterey Peninsula The Scope of the Problem 1-5 Opiate use in the US 80% of the world s prescription opiate supply 99% of the world s hydrocodone supply From 1997
More informationBalance chronic pain management and responsible opioid prescribing. Michelle Bardack, M.D. Family & Community Medicine April 27, 2011
Balance chronic pain management and responsible opioid prescribing Michelle Bardack, M.D. Family & Community Medicine Overview Frame the dilemma Federation of State Medical Boards Discussion and questions
More informationOpioid Addiction Statistics
May 2017 Opioid Addiction Statistics Definitions Heroin Epidemic - As pill mills close, prescribing is becoming tighter, demand among younger users rise, and dealer s profits rise, addicts are turning
More informationPACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives
PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION Chronic Pain and Opiate Management Initiatives Objectives To enhance understanding of current concepts, guidelines and risks of
More informationPain Management and Addiction: Clinical Challenges
Pain Management and Addiction: Clinical Challenges MMS Pain Management Forum March 12, 2010 Associate Professor of Medicine Boston University School of Medicine Boston Medical Center Conflicts of Interest
More informationValue of Abuse-Deterrent Opioids. For your personal use. Not for further distribution.
Value of Abuse-Deterrent Opioids HHS Data Show that Prescription Opioid Abuse Continues To Be a Serious Public Health Issue At least half of all opioid overdose deaths in the United States (US) involve
More informationURINE DRUG TOXICOLOGY
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences URINE DRUG TOXICOLOGY Suzanne E. Rapp, MD GENERAL DISCLOSURES The University of Washington School of Medicine also
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationOxycodone. Dr Alistair Dunn Addiction Medicine Specialist & General Practitioner
Oxycodone Dr Alistair Dunn Addiction Medicine Specialist & General Practitioner Whangarei, Northland. Oxycodone Dr Alistair Dunn Addiction Medicine Specialist Whangarei, Northland. CRUSADER! Oxycodone
More informationChallenges in Conducting Postmarketing Abuse Investigations
Challenges in Conducting Postmarketing Abuse Investigations Paul Coplan, ScD, MBA Risk Management & Epidemiology Purdue Pharma, L.P. ADF Guidance Meeting Washington DC, October 1, 2013 1 That which we
More informationOregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
More informationThe Population is Abusing Drugs, but are Drugs Abusing Insurance?
Image licensed from Shutterstock The Population is Abusing Drugs, but are Drugs Abusing Insurance? 01/30/2018 Gina C. Guzman, MD, DBIM, FALU, FLMI, VP and Chief Medical Director Tim Morant, FSA, MAAA,
More informationDr Alistair Dunn. General Practitioner Northland District Health Board Whangarei
Dr Alistair Dunn General Practitioner Northland District Health Board Whangarei Oxycodone Dr Alistair Dunn Addiction Medicine Specialist General Practitioner Whangarei, Northland. Oxycodone Dr Alistair
More informationMedical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses
Identifying and Preventing Drug Abuse By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Medical vs. Non-Medical Use of Drugs Intent Effect
More informationIncrease in Opioid Related Deaths What the Data Can Tell us. Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes
Increase in Opioid Related Deaths What the Data Can Tell us Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes Objectives Prescription Opioid Misuse and Abuse: How did we get here? Opioid
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationA brief history of urine drug testing. Forging a common vocabulary for urine drug testing
A brief history of urine drug testing Forging a common vocabulary for urine drug testing Gary M. Reisfield, M.D. Assistant Professor and Director Division of Pain and Palliative Medicine Department of
More informationOpioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018
Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018 Disclosures None Educational Objectives Understand CA state medical board guidelines for prescribing opioids for chronic pain Understand the
More informationMANAGING PAIN WHILE MINIMIZING RISK OF SUBSTANCE USE DISORDER OUTLINE. EPIDEMIC / CRISIS The Epidemic / Crisis Around Opioid Prescription Use
MANAGING PAIN WHILE MINIMIZING RISK OF SUBSTANCE USE DISORDER Barbara St. Marie, PhD, ANP, GNP, ACHPN Associate Faculty College of Nursing University of Iowa, Iowa City, IA OUTLINE Epidemic / Crisis Foundational
More informationOpioids for Chronic Pain: COPYRIGHT. An Approach to Decision Making, Risk Management, & Monitoring
Opioids for Chronic Pain: An Approach to Decision Making, Risk Management, & Monitoring Marc Cohen MD Julia Lindenberg, MD Update in Internal Medicine 2016 Case n 51 y/o female with h/o bipolar disorder,
More informationKey points. Background
RADARS System Technical Report # 2012Q3-1 Prescription Opioid Abuse and Misuse rates from RADARS System are Highly Correlated with Rates from The Drug Abuse Warning Network (DAWN) Key points The RADARS
More informationBest Practices in Prescribing Opioids for Chronic Non-cancer Pain
Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G
More informationShining a Light on MEDs Understanding morphine equivalent dose
Shining a Light on MEDs Understanding morphine equivalent dose In the workers compensation industry, 60.2 percent of claimants utilize opioid analgesics for the treatment of pain caused by a workplace
More informationLessons Learned from the US Prescription Opioid Abuse Epidemic
Lessons Learned from the US Prescription Opioid Abuse Epidemic Michelle Lofwall, M.D. University of KY, Dept. of Psychiatry Center on Drug and Alcohol Research October 3, 2012 Outline for today s talk
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationRAPID Analysis of Routes of Administration: Oral to Non-Oral Transitions
RAPID Analysis of Routes of Administration: Oral to Non-Oral Transitions Dr. Theodore J. Cicero, PhD John P. Feighner Professor of Psychiatry Washington University in St. Louis, MO RAPID Program Overview
More informationClinical and Contextual Evidence Reviews
Clinical and Contextual Evidence Reviews Roger Chou, MD Professor of Medicine Oregon Health & Science University Director, Pacific Northwest Evidence-based Practice Center Purpose Summarize methods for
More informationTrainwreck: Addressing Complex Pharmacotherapy With the Inherited Pain Patient
Trainwreck: Addressing Complex Pharmacotherapy With the Inherited Pain Patient Douglas Gourlay MD, MSc, FRCPC, FASAM Disclosures Nothing to disclose 2 1 Learning Objectives Assess the prescription drug
More informationWhat do they have in common?
What do they have in common? Opioid use in USA Approximately 9 million people on long term opioids Approximated 5 million people reporting non-medical use of opioids 1997: 96mg/person morphine eq dispensed
More informationOpioids drive continued increase in drug overdose deaths
CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th
More informationHow Can a Methadone and an Opiate-Positive Immunoassay Result be Reconciled in a Patient Prescribed only OxyContin and Wellbutrin?
190 Available online at www.annclinlabsci.org How Can a Methadone and an Opiate-Positive Immunoassay Result be Reconciled in a Patient Prescribed only OxyContin and Wellbutrin? Jude M. Abadie Department
More information6/14/2017. I have no actual or potential conflict of interest in relation to this program/presentation.
Sheila Weix MSN, RN, CARN smw June 2017 1 I have no actual or potential conflict of interest in relation to this program/presentation. I am not A recipient of grant or research funds from any company A
More informationThe Opioid Crisis Made in America Fade in America?
The Opioid Crisis Made in America Fade in America? The President s Commission On Combating Drug Addiction and the Opioid Crisis Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry
More informationOpioid Abuse: What it means to Medicine
Opioid Abuse: What it means to Medicine Bruce Bonanno, MD, FACEP No declarations NJ ACEP President 2010 11 NJ PMP instituted Prescription Drug Abuse Campaign: ACEP March 2012 2015 NJ ACEP Opiate Abuse
More informationOpioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities
1 National Academy of Medicine Session 4 Opioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center
More informationCentral Oregon Pain Standards Task Force Strategic Initiatives 2015
Central Oregon Pain Standards Task Force Strategic Initiatives 2015 Kim Swanson, Ph.D. Behavioral Health Consultant/Licensed Psychologist Chair, Pain Standards Task Force Acknowledgements Central Oregon
More informationPost-Marketing Surveillance: Lessons Learned and Recommendations for the Future
+ Post-Marketing Surveillance: Lessons Learned and Recommendations for the Future Dr. Theodore J. Cicero, PhD Washington University in St. Louis, Department of Psychiatry + Conflicts of Interest/Disclosure
More informationPROP. physicians for responsible opioid prescribing. March 29, Dear State Medical Board Member:
PROP physicians for responsible opioid prescribing PRESIDENT Andrew Kolodny, MD BROOKLYN, NY VICE PRESIDENT Michael Von Korff, ScD TREASURER Rosemary Orr, MD SECRETARY Stephen Gelfand, MD MYRTLE BEACH,
More informationOPIOID CRISIS: A PERSPECTIVE. Karl J. Haake, MD
OPIOID CRISIS: A PERSPECTIVE Karl J. Haake, MD LEARNING OBJECTIVES Summarize the history behind the opioid epidemic in America Identify the issues surrounding the the treatment of chronic pain Demonstrate
More informationPain and Addiction. Edwin A. Salsitz, MD, FASAM. Mount Sinai Beth Israel New York, New York
Pain and Addiction Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel New York, New York ASAM Disclosure of Relevant Financial Relationships Content of Activity: ASAM Review Course 2014 Name Commercial
More informationSpotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017
Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic October 25, 2017 Disclosures and Disclaimer Neither the Institute for Health Policy and Leadership (IHPL) nor I have any relevant financial
More informationWhat is a lethal dose of oxycodone
Cari untuk: Cari Cari What is a lethal dose of oxycodone 25-2-2018 In people that are not tolerant of opioids, a single dose of 40 milligrams or a total daily dose of 80 milligrams of oxycodone has the
More informationUrine Drug Testing PracticeNotes Clinical Guide
PracticeNotes Clinical Guide This PracticeNotes Clinical Guide offers a quick overview of the essentials of a patient-centered approach to urine drug testing (UDT), which remains an important tool for
More informationInterstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science
Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis,
More informationResponding to the Opioid Addiction Epidemic
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist,
More informationPrescription Drug Abuse
Prescription Drug Abuse Providers Need Drug Rehab Before They Can Lead Our Nation Into Recovery Roneet Lev, MD FACEP SCOPE OF PROBLEM Health Ledger 1979-2008 Oxycodone Hydocodone Diazepam (valium) Temazepam
More informationVirtual Mentor American Medical Association Journal of Ethics April 2014, Volume 16, Number 4:
Virtual Mentor American Medical Association Journal of Ethics April 2014, Volume 16, Number 4: 279-283. POLICY FORUM OxyContin, the FDA, and Drug Control Gary M. Reisfield, MD One percent of people will
More informationThe Prescription Drug Overdose Epidemic
The Prescription Drug Overdose Epidemic Rita Noonan, PhD National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More information4/3/2018. The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers. Learning Objectives
The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers Melissa Durham Tania Gregorian Vlada Manzur Learning Objectives Describe current issues
More informationPharmaceutical Fentanyl s (PF) Role in Fentanyl- related Overdose Deaths
Pharmaceutical Fentanyl s (PF) Role in Fentanyl- related Overdose Deaths Paper presented at the 2018 annual meetings of the American Public Health Association, San Diego, CA Session 5061.0: Impact of fentanyl
More informationData Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky
Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots
More informationHouse of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home. MAJ Meghan Raleigh, MD 17 MAR 2014
House of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home MAJ Meghan Raleigh, MD 17 MAR 2014 Make this house your own! Objectives Review key components in PCMH Identify
More informationLethal doses of oxycodone
Cari untuk: Cari Cari Lethal doses of oxycodone Mambog, Mitragyna speciosa, KRATOM - Herbal Medicine - An illustrated compilation of Philippine medicinal plants by Dr Godofredo Umali Stuart with botanical.
More information9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A
Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin
More informationTrust but verify is good advice
PRINTER-FRIENDLY VERSION Available AT PainMedicineNews.com The Role of Urine Drug Monitoring in Pain Management Lynn R. Webster, MD Medical Director CRILifetree Research Salt Lake City, Utah President
More informationThe Role of the Emergency Department in the Opioid Epidemic. Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital
The Role of the Emergency Department in the Opioid Epidemic Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital Disclosures Treasurer, Massachusetts College of Emergency
More informationWhite Paper on. Prescription Drug Abuse
White Paper on Prescription Drug Abuse October 22, 2014 Table of Contents: I. Introduction II. Scope of the Problem III. Most Common Drugs Involved in Overdoses IV. Efforts in Tennessee V. Prescription
More information2017 Erin Jackson For presentation at IPTA Revitalize
Slide 1 The Opioid Epidemic & Physical Therapy Presenter: Erin K. Jackson, JD, MA 2017 CONFERENCE & EXPO Slide 2 Plan Hour one: Overview of the epidemic Hour two: Legal and ethical obligations Hour three:
More informationEffect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids
Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids Richard C. Dart, MD, PhD Executive Director, RADARS System Professor, University of Colorado Competing
More informationProject Narcan: BPD officers equipped with life-saving rescue drug
From: Kelli Williams, Chief Communications Officer City of Bartlesville Date: Oct. 24, 2017 For release: Immediate Project Narcan: BPD officers equipped with life-saving rescue drug By Kelli Williams City
More informationDying To Ease The Pain WA State Experience with Opiate Overdoses WA State Attorney General Summit June 15 th, Stephen H. Anderson MD, FACEP
Dying To Ease The Pain WA State Experience with Opiate Overdoses WA State Attorney General Summit June 15 th, 2017 Stephen H. Anderson MD, FACEP Stephen H. Anderson MD Practicing ED Physician MultiCare
More informationSafe and Competent Opioid Prescribing
MILITARY Military Safe and Competent Opioid Prescribing Education (M-SCOPE) Program Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Daniel P. Alford,
More informationAnalysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
Article in press - uncorrected proof Clin Chem Lab Med 2009;47(8):971 976 2009 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2009.220 2009/180 Analysis and interpretation of drug testing results
More informationMANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling
MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin
More informationOpioid epidemic and PEHP
Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe
More informationWhat are symptoms of oxycodone withdrawal? Once an oxycodone user lowers the dosage by more than 1/2 at a time or stops taking oxycodone altogether,
What are symptoms of oxycodone withdrawal? Once an oxycodone user lowers the dosage by more than 1/2 at a time or stops taking oxycodone altogether, the body starts manifesting withdrawal symptoms. Vitamin
More informationIllicit Drug Use Correlates with Negative Urine Drug Test Results for Prescribed Hydrocodone, Oxycodone, and Morphine
Pain Physician 2012; 15:E687-E692 ISSN 2150-1149 Retrospective Evaluation Illicit Drug Use Correlates with Negative Urine Drug Test Results for Prescribed Hydrocodone, Oxycodone, and Morphine Amadeo Pesce,
More informationKnock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
More informationWelcome - we will begin the webinar shortly Please read the participation tips below:
Welcome - we will begin the webinar shortly Please read the participation tips below: All guest phones have been muted: Background noises, conversations, white noise etc., can be disruptive to a webinar.
More informationManaging Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.
Managing Narcotics on Workers Comp Claims Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc. October 21, 2014 Outline Rationale Scope list drug list Recommended
More informationFentanyl, Opioid Overdose and Naloxone
Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians
More informationObjectives. Disclosures
Pain Management in Individuals with Serious Illness and Co-morbid Substance Use Disorders Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN Nurse Practitioner Section of Palliative Care Assistant Professor
More informationTop 10 narcotic pain pills
Top 10 narcotic pain pills Click to go to the item or just scroll down the page. Doctors Respond to FDA Panel Recommendations FDA Considers Banning Popular Prescription Pain Medications and. Top 10 Natural
More information